The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Dec. 21, 2018
Applicant:

Codagenix Inc., Farmingdale, NY (US);

Inventors:

John Robert Coleman, New York, NY (US);

Steffen Mueller, Great Neck, NY (US);

Chen Yang, Plainview, NY (US);

Ying Wang, South Setauket, NY (US);

Charles Stauft, Wheatley Heights, NY (US);

Assignee:

CODAGENIX INC., Farmingdale, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); A61K 39/13 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 39/13 (2013.01); A61K 39/145 (2013.01); C12N 7/00 (2013.01); A61K 39/39558 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/812 (2018.08); A61K 2039/86 (2018.08); A61K 2039/876 (2018.08); C12N 2760/16132 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/32632 (2013.01);
Abstract

The present invention is the use of designed recombinant viruses for the treatment of various forms of malignant tumors. The recombinant viruses of the invention are those in which one or more regions of the wild type virus was exchanged with a synthetic recoded sequence that reduces the codon pair score relative to human codon pair bias, or that increase the number for CpG di-nucleotides, or that increases the number of UpA di-nucleotides. The method of the present invention is particularly useful for the treatment of malignant tumors in various organs, such as: breast, skin, colon, bronchial passage, epithelial lining of the gastrointestinal, upper respiratory and genito-urinary tracts, liver, prostate and the brain. Astounding remissions in experimental animals have been demonstrated for the treatment of malignant glioblastoma multiforme, as well as for the treatment of breast cancer and melanoma as well.


Find Patent Forward Citations

Loading…